Investing Profile

Andrew Schiff


Photo of Andrew Schiff, Managing Partner at Aisling Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Aisling Capital Managing Partner
CompanyStageDateRound SizeTotal Raised
Forge Biologics
Series CSep 2022$90M
Co-investors: Chris Garabedian (Perceptive Advisors)
Dren Bio
Series BJun 2022$65M
Co-investors: Sakae Asanuma (Taiho Ventures)
Monte Rosa Therapeutics
Series BSep 2020$96M
Co-investors: Ali Behbahani (New Enterprise Associates (NEA)), Markus Warmuth (Versant Ventures), Alexander Mayweg (Versant Ventures)
Zavante Therapeutics
Series AMar 2016$45M
Co-investors: Patrick Heron (Frazier Healthcare Partners)
Agile Therapeutics
Post-IPO EquityFeb 2015$20M
Series CJul 2012$40M
Co-investors: Karen Hong (Novo Ventures), Stacey Seltzer (Aisling Capital)
Miramar Labs
Series DOct 2014$26M
Co-investors: Hank Plain (Morgenthaler Ventures)
Zeltiq Aesthetics
Series DJun 2010$25M
Co-investors: Bryan Roberts (Venrock)
Asensus Surgical
Post-IPO EquityOct 2009$55M
Co-investors: Paul LaViolette (SV Health Investors)